Table 1. Genes represented by the ARS and their correlation with platelet function with aspirin*.
Affymetrix Probe ID |
Gene Symbol |
Gene Description | Combined PFS beta coefficient * |
Combined P-value |
---|---|---|---|---|
Factor 14 | n/a | n/a | −0.76088 | 0.0017 |
Individual Factor 14 transcripts | ||||
208782_at | FSTL1 | follistatin-like 1 | −1.6579 | 0.0003 |
201059_at | CTTN | cortactin | −1.2817 | 0.0015 |
201906_s_at | CTDSPL | CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
−1.3795 | 0.0025 |
1555659_a_at | TREML1 | triggering receptor expressed on myeloid cells-like 1 |
−1.0767 | 0.0034 |
212667_at | SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | −1.214 | 0.0048 |
216956_s_at | ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
−1.0689 | 0.0048 |
230942_at | CMTM5 | CKLF-like MARVEL transmembrane domain containing 5 |
−1.1641 | 0.0061 |
57588_at | SLC24A3 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
−1.3053 | 0.0063 |
207550_at | MPL | myeloproliferative leukemia virus oncogene | −0.931 | 0.0066 |
219090_at | SLC24A3 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
−1.1123 | 0.0080 |
208791_at | CLU | clusterin | −0.9584 | 0.0085 |
206494_s_at | ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
−0.7279 | 0.0087 |
227189_at | CPNE5 | copine V | −1.2062 | 0.0088 |
220496_at | CLEC1B | C-type lectin domain family 1, member B | −1.2077 | 0.0090 |
206493_at | ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
−0.8966 | 0.0094 |
206049_at | SELP | selectin P (granule membrane protein 140kDa, antigen CD62) |
−1.1642 | 0.0104 |
203819_s_at | IGF2BP3 | insulin-like growth factor 2 mRNA binding protein 3 |
−1.2947 | 0.0123 |
225354_s_at | SH3BGRL2 | SH3 domain binding glutamic acid-rich protein like 2 |
−1.0895 | 0.0146 |
207808_s_at | PROS1 | protein S (alpha) | −1.1049 | 0.0174 |
207206_s_at | ALOX12 | arachidonate 12-lipoxygenase | −0.8756 | 0.0207 |
212813_at | JAM3 | junctional adhesion molecule 3 | −1.0454 | 0.0215 |
1560262_at | LRRC32 | leucine rich repeat containing 32 | −0.9376 | 0.0226 |
204628_s_at | ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
−0.968 | 0.0242 |
214146_s_at | PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
−0.713 | 0.0243 |
211026_s_at | MGLL | monoglyceride lipase | −1.0027 | 0.0249 |
208792_s_at | CLU | clusterin | −0.8122 | 0.0266 |
201108_s_at | THBS1 | thrombospondin 1 | −0.9169 | 0.0276 |
201058_s_at | MYL9 | myosin, light chain 9, regulatory | −0.5909 | 0.0287 |
206390_x_at | PF4 | platelet factor 4 (chemokine (C-X-C motif) ligand 4) |
−0.9017 | 0.0296 |
206655_s_at | GP1BB | glycoprotein Ib (platelet), beta polypeptide | −0.8934 | 0.0317 |
209651_at | TGFB1I1 | transforming growth factor beta 1 induced transcript 1 |
−0.7618 | 0.0326 |
207414_s_at | PCSK6 | proprotein convertase subtilisin/kexin type 6 | −0.8566 | 0.0351 |
200665_s_at | SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | −0.8261 | 0.0410 |
212077_at | CALD1 | caldesmon 1 | −0.5688 | 0.0505 |
203817_at | GUCY1B3 | guanylate cyclase 1, soluble, beta 3 | −0.8511 | 0.0546 |
227088_at | PDE5A | phosphodiesterase 5A, cGMP-specific | −0.918 | 0.0571 |
226152_at | TTC7B | tetratricopeptide repeat domain 7B | −0.7986 | 0.0594 |
206167_s_at | ARHGAP6 | Rho GTPase activating protein 6 | −0.8437 | 0.0677 |
37966_at | PARVB | parvin, beta | −0.7708 | 0.0717 |
208601_s_at | TUBB1 | tubulin, beta 1 | −0.5959 | 0.0736 |
204115_at | GNG11 | guanine nucleotide binding protein (G protein), gamma 11 |
−0.5622 | 0.1229 |
241133_at | PRSS1 | protease, serine, 1 (trypsin 1) | −0.4814 | 0.1243 |
203680_at | PRKAR2B | protein kinase, cAMP-dependent, regulatory, type II, beta |
−0.5049 | 0.1365 |
205442_at | MFAP3L | microfibrillar-associated protein 3-like | −0.4724 | 0.1385 |
212151_at | PBX1 | pre-B-cell leukemia transcription factor 1 | −0.6059 | 0.1729 |
212573_at | ENDOD1 | endonuclease domain containing 1 | −0.7276 | 0.1735 |
230690_at | TUBB1 | tubulin, beta 1 | −0.578 | 0.1864 |
230645_at | FRMD3 | FERM domain containing 3 | −0.6391 | 0.2102 |
225974_at | TMEM64 | transmembrane protein 64 | 0.38321 | 0.2227 |
1553842_at | BEND2 | chromosome × open reading frame 20 | −0.5657 | 0.2258 |
228708_at | RAB27B | RAB27B, member RAS oncogene family | −0.4836 | 0.2512 |
227180_at | ELOVL7 | ELOVL family member 7, elongation of long chain fatty acids (yeast) |
−0.3943 | 0.2823 |
212148_at | PBX1 | pre-B-cell leukemia transcription factor 1 | −0.3139 | 0.2970 |
203414_at | MMD | monocyte to macrophage differentiation-associated | −0.4287 | 0.3236 |
1552773_at | CLEC4D | C-type lectin domain family 4, member D | 0.37545 | 0.3543 |
222717_at | SDPR | serum deprivation response (phosphatidylserine binding protein) |
−0.3009 | 0.3830 |
224823_at | MYLK | myosin, light chain kinase | −0.2911 | 0.4644 |
214974_x_at | CXCL5 | chemokine (C-X-C motif) ligand 5 | −0.1621 | 0.5011 |
229778_at | C12ORF39 | chromosome 12 open reading frame 39 | −0.2032 | 0.5020 |
235331_x_at | PCGF5 | polycomb group ring finger 5 | 0.22781 | 0.5470 |
212651_at | RHOBTB1 | Rho-related BTB domain containing 1 | −0.2395 | 0.5755 |
206110_at | HIST1H3H | histone cluster 1, H3h | −0.2021 | 0.5827 |
215779_s_at | HIST1H2BG | histone cluster 1, H2bg | −0.2623 | 0.5896 |
207815_at | PF4V1 | platelet factor 4 variant 1 | −0.0927 | 0.6139 |
226188_at | LGALSL | lectin, galactoside-binding-like− | 0.23728 | 0.6142 |
221556_at | CDC14B | CDC14 cell division cycle 14 homolog B (S. cerevisiae) |
−0.2127 | 0.6530 |
207156_at | HIST1H2AG | histone cluster 1, H2ag | −0.1534 | 0.6882 |
210387_at | HIST1H2BG | histone cluster 1, H2bg | −0.1494 | 0.6906 |
225166_at | ARHGAP18 | Rho GTPase activating protein 18 | 0.15541 | 0.7353 |
206272_at | RAB4A | RAB4A, member RAS oncogene family | 0.09962 | 0.7967 |
210986_s_at | TPM1 | tropomyosin 1 (alpha) | 0.08749 | 0.8404 |
227451_s_at | C6ORF79 | chromosome 6 open reading frame 79 | −0.0134 | 0.9791 |
= the beta coefficient for the expression of either the aggregate expression of the ARS or each probe set represented by the ARS using the combined HV1 and HV2 datasets from a regression model containing gene expression and cohort (HV1 vs. HV2) with corresponding p-value; PFS = platelet function score.